ASH 2009: Multiple Myeloma Treatment Costs Vary Widely

[annie]

ASH2009: Multiple Myeloma Treatment Costs Vary Widely
Fuente:
Medpage today
By Ed Susman, Contributing Writer, MedPage Today
Published: December 06, 2009
Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. Earn CME/CE credit
for reading medical news
Cita:

NEW ORLEANS - Results of a cost analysis that compared multiple myeloma treatments found that treatment with bortezomib (Velcade) was associated with less out-of-pocket expenses than was treatment with the oral medications lenolidomide (Revlimid) and thalidomide (Thalomid).

"Multiple myeloma is a complex disease that places a significant burden on patients or their caregivers," said Brett Pinsky, MPH, a senior researcher at i3 Innovus, Eden Prairie, Minn., in a poster presentation at the American Society of Hematology meeting.........."
Fin de la cita.
Leer mas en:
http://www.medpagetoday.com/MeetingCove ... logy/17352
Traducido en:
http://www.translate.google.es/translat ... l=en&tl=es

[fercu]

Da inquietud que estos gastos
no sean soportables en un futuro por la SS.

Abrazos fercu y mary